2022
TOTAL:35 NEWS
First Patient Enrolled for Zhaoke Ophthalmology’s Myopia Progression Control Drug NVK002 Phase III Bridging Clinical Trial (Mini-CHAMP) in China
2022-05-2066
Visus Therapeutics, Inc., and Zhaoke Ophthalmology Limited Announce Exclusive Licensing Agreement to Commercialize BRIMOCHOL™ PF and Carbachol PF in Greater China, South Korea and Select Southeast Asian Markets for the Treatment of Presbyopia
2022-05-11192
Zhaoke Ophthalmology Presented the Results of the Phase III Clinical Trial (COSMO) of CsA Ophthalmic Gel at ARVO 2022 Annual Meeting
2022-05-05130
Zhaoke Ophthalmology Announces 2021 Annual Results
2022-03-23246
First Patient Enrolled for the Phase III Clinical Trial of Zhaoke Ophthalmology’s Myopia Drug, NVK002
2022-03-23126